Ziopharm expected to rebound

Mad Money's Jim Cramer expects Ziopharm Oncology Inc. (Nasdaq: ZIOP) to rebound. Shares of the biotechnology firm climbed $1.41 to close at $11.64.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.